Ensuring vaccine safety is paramount in the NIP. Rigorous clinical trials and continuous post-marketing surveillance are conducted to monitor the safety and efficacy of vaccines. Adverse events following immunization (AEFI) are systematically recorded and investigated to maintain public trust and ensure the safety of the immunization program.
